Search Results

IDbyDNA’s metagenomic approach to viral strain identification combines very sensitive detection with next-gen sequencing to identify emerging and mutant viruses much sooner than either genomic or surveillance methods alone.

IDbyDNA, the company revolutionizing the use of Precision Metagenomics, has been awarded a second year of funding by MRIGlobal to continue participation in the “Detect It with Gene Editing Technologies” program for the United States Defense Advanced Research Projects Agency.

IDbyDNA, a precision metagenomics company offering next-generation-sequencing-based infectious disease testing and anti-microbial resistance profiling, today announces that it has appointed Susan (Siw) E. Daniels, Ph.D., as Vice President of R&D and a member of the company’s executive committee.

IDbyDNA, Inc., a metagenomics technology company setting the standard for detection, identification and interpretation of microorganisms and their role in human health, announced that its currently available Explify Respiratory test can detect 2019-nCoV in addition to over 900 other viral, bacterial, fungal and parasitic pathogens.

Partnership Aims to Accelerate NGS Adoption for Clinical Infectious Disease Testing by Combining Comprehensive Sequencing Workflows with Turn-key Clinical Informatics SAN FRANCISCO--( BUSINESS WIRE )-- IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation of microorganisms and their role in human health, today announced a global strategic partnership with Illumina, Inc. (Nasdaq: ILM

IDbyDNA, Inc., a metagenomics technology company setting the standard for detection, identification, and interpretation of microorganisms and their role in human health, today announced the raise of $20 million in its Series B financing led by ARTIS Ventures and joined by Genesys Capital and others.

IDbyDNA, a metagenomics technology company setting a new standard for the identification and understanding of microorganisms and their role in human health, today announced the appointment of two new members to its Scientific Advisory Board (SAB).

IDbyDNA, a metagenomics technology company setting a new standard for the identification and understanding of microorganisms and their role in human health, today announced a commercial agreement with ZeptoMetrix, a world leading laboratory quality control (QC) and reference materials supplier

IDbyDNA, a metagenomics technology company providing more actionable Infectious Disease test results, today announced that it will present at the Digital Medicine and Medtech Showcase 2019, occurring January 7-9, 2019 at the Parc 55 in San Francisco

Metagenomics can look across the entire genomic sequence of more than 50,000 species of organisms that may be present in a patient sample and compare millions of sequences from a patient with millions of reference sequences.